Millipede88® Super-Bore Aspiration Catheter, delivered with the Zipline88® Access Catheter, positioned at the site of occlusion. (Illustration; not clinical imagery). Millipede88 achieved the highest first pass effect and revascularization rates, with the lowest distal embolization, across both MCA and ICA occlusions. Perfuze®, a medical device company advancing stroke treatment through next-generation catheter technology, today announced the publication of a peer-reviewed …
Explore
